REQUEST A DEMO
Total
USD $0.00
Search more companies

Guizhou Xinbang Pharmaceutical Co., Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Guizhou Xinbang Pharmaceutical Co., Ltd Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

This is a pharmaceutical company based on the integration of planting, drug development, production and sales. The main product category includes heart and brain blood vessels and digestive. The company has 44 varieties of the product with code number approved by SFDA, including 24 varieties of national basic medical insurance, the state four varieties at competitive prices, 4 species protective medicine, 2 exclusive varieties. Liuwei Anxiao capsule which is currently the first multi-center clinical study of all-natural gastrointestinal motility, Yixin capsule has maintained a 100% market share; Ginkgo biloba for the national armed forces within the hospital system exclusive successful varieties. Currently, the company has 11 varieties in the research, of which 43 million investment in research and development with independent intellectual property rights of New Drug for ginsenoside-Rd Injection has completed Phase Ⅲ clinical summary; mental health drugs medicine six capsules, eight categories of Chinese medicine Breviscapine pills clinical trials have been completed, pending the production of approval.

Headquarters
No. 83, North Section of Xintian Avenue, Wudang District, Guiyang City, Guizhou Province
Guiyang; Guizhou; Postal Code: 550018

Contact Details: Purchase the Guizhou Xinbang Pharmaceutical Co., Ltd report to view the information.

Website: http://www.xinbang.com

Basic Information
Total Employees:
Purchase the Guizhou Xinbang Pharmaceutical Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Guizhou Xinbang Pharmaceutical Co., Ltd report to view the information.
Registered Capital:
Purchase the Guizhou Xinbang Pharmaceutical Co., Ltd report to view the information.
Financial Auditors:
Purchase the Guizhou Xinbang Pharmaceutical Co., Ltd report to view the information.
Incorporation Date:
January 27, 1995
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
18.52%
Purchase this report to view the information.
18.46%
Purchase this report to view the information.
5.04%
Purchase this report to view the information.
1.17%
Purchase this report to view the information.
1.12%
Subsidiaries
Anhui Tongde Chinese Medicinal Materials Development Co., Ltd.
Baiyun Hospital Affiliated to Guizhou Medical University
Gansu Tongde Daodi Pharmaceutical Co., Ltd.
Company Performance
Financial values in the chart are available after Guizhou Xinbang Pharmaceutical Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-5.35%
Total operating revenue
-5.3%
Operating profit (EBIT)
-21.36%
Net Profit (Loss) for the Period
-23.3%
Total assets
-7.59%
Total equity
-0.68%
Operating Profit Margin (ROS)
-1.2%
Net Profit Margin
-1.19%
Return on Equity (ROE)
-0.97%
Debt to Equity Ratio
-7.19%
Quick Ratio
0.47%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?